Testing effectiveness (Phase 2)Study completedNCT00816023
What this trial is testing
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
Who this might be right for
BloodlossSurgical Procedures, Operative
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 276